![Granules Avatrombopag Maleate](https://www.pharmacompass.com/image/flap/granules-avatrombopag-maleate-desktop-headergif-21368.gif)
![Granules Avatrombopag Maleate](https://www.pharmacompass.com/image/flap/granules-avatrombopag-maleate-mobgif-55430.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
USA (Orange Book)
Europe
0
Canada
Australia
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
1. E5501 Maleate
2. 677007-74-8
3. Avatrombopag Maleate [usan]
4. Avatrombopag Meleate
5. Avatrombopag (maleate)
6. Gdw7m2p1is
7. E-5501 Maleate
8. (z)-but-2-enedioic Acid;1-[3-chloro-5-[[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl]pyridin-2-yl]piperidine-4-carboxylic Acid
9. 4-piperidinecarboxylic Acid, 1-(3-chloro-5-(((4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1- Piperazinyl)-2-thiazolyl)amino)carbonyl)-2-pyridinyl)-, (2z)-2-butenedioate (1:1)
10. Unii-gdw7m2p1is
11. Doptelet (tn)
12. Akr-501 Monomaleate
13. Chembl2105758
14. Schembl19610454
15. Avatrombopag Maleate [mi]
16. Avatrombopag Maleate (jan/usan)
17. Avatrombopag Maleate [jan]
18. Dtxsid001027855
19. 677007-74-8 (maleate)
20. Hy-13463a
21. Avatrombopag Maleate [who-dd]
22. Avatrombopag Maleate [orange Book]
23. Cs-0025423
24. D10307
25. A902459
26. Q27279052
27. 1-(3-chloro-5-((4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2- Yl)carbamoyl)pyridin-2-yl)piperidine-4-carboxylic Acid Mono-(2z)-but-2-enedioate
28. 1-[3-chloro-5-[[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl]pyridin-2-yl]piperidine-4-carboxylic Acid;avatrombopag
Molecular Weight | 765.7 g/mol |
---|---|
Molecular Formula | C33H38Cl2N6O7S2 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 9 |
Exact Mass | 764.1620453 g/mol |
Monoisotopic Mass | 764.1620453 g/mol |
Topological Polar Surface Area | 233 Ų |
Heavy Atom Count | 50 |
Formal Charge | 0 |
Complexity | 1050 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Doptelet is indicated for the treatment of severe thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo an invasive procedure.
Doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments (e. g. corticosteroids, immunoglobulins).
Treatment of Idiopathic Thrombocytopenia Purpura (ITP), Treatment of Thrombocytopenic Purpura Secondary to Liver Disease
B02BX